Ger Van Jeveren

Slingshot Ventures is a Dutch venture capital fund solely backed by successful entrepreneurs. We back ambitious, talented and charismatic entrepreneurs and actively help them accelerate their businesses with our knowledge, experience and international network of people and companies. By providing smart growth capital we help these start- and scale-ups catapult their business to the next level. This makes us the partner of choice for B2(B2)C focused fast growing ventures with international growth ambition and potential. We believe that proven entrepreneurs are the best inspiration for the next generation of entrepreneurs. That’s why both our team and our carefully selected group of investors consist of proven entrepreneurs and venture builders. This makes us truly hands-on in our investment approach. It’s what we call “inspirational growth capital”. We currently manage a portfolio of multiple investments, all with a base in the Netherlands and all with a cross-border ambition. Our portfolio includes companies such as Swishfund (online business lender), The Fabricant (digital fashion house)Temper (online marketplace for freelancers), Wasteless (dynamic pricing solution for supermarkets), Stox Energy Socks (innovative pressure socks), Fangage (all in one fan platform), Toothfairy (smart dental app), Check (shared e-moped platform) & Boldking (online male grooming).

Ace Pharmaceuticals Belgium is the subsidiary of Ace Pharmaceuticals BV, established in the Netherlands. Ace is a pharmaceutical company with more than 120 employees. We develop, produce, register and sell medicines with a specific medical need. We do all this in-house. We are committed to making and keeping medicines with a specific medical need available. These are often medicines that are indispensable for a (small) specific group of patients or indication. Ace also takes care of the production and distribution of medicines for clinical research. In addition to registered medicines, we, as GMP manufacturer, also produce and supply pharmaceutical compounding on behalf of hospital pharmacies. In our state-of-the-art preparation facilities, we have all preparation facets in-house. We produce tablets and capsules, creams and ointments, but also aseptic and sterile preparations.

Nous distribuons les matières premières à usage pharmaceutique de Pharmachemicals Belgique. Depuis plus de 40 ans, les pharmaciens fondateurs de Pharmachemicals ont acquis une expérience dans le domaine de la préparation magistrale. Ils ont créé par le passé plusieurs sociétés spécialisées dans le sourcing, l’analyse et le reconditionnement de ces matières premières.

NewPort Capital is an independent private equity firm focused on investing in Dutch based companies with a proven track record, considerable growth potential, and a strong and ambitious management team. NewPort is fully funded by successful Dutch entrepreneurs and the NewPort team. With over 60 business owners from various sectors on its side, NewPort can justifiably claim to be an entrepreneurial investor. NewPort’s strength lies in providing strategic, financial and operational expertise, leveraging on our extensive network and offering growth capital. Growth in the broadest sense is realised by investing in businesses with whom we jointly develop a growth strategy. The business owner and management team remain or become partial shareholders according to their means, and continue to be responsible for the day-to-day management of the business: NewPort acts as a critical and engaged shareholder, functioning as a sounding board and sparring partner, and supporting the company with its network. Based on mutual trust and shared ambitions, we aim to strengthen the company together and realise value creation in the medium term. The businesses we invest in are generally characterised by a solid market position, a differentiating factor and ample growth potential. The latter may involve autonomous or acquisitive growth, either national or international. The NewPort team has a wealth of experience in supporting management teams in realising growth and value creation. We focus on investments in majority shareholdings in existing Dutch (often internationally active) mid-market companies in the manufacturing, business or financial service industries, and the food and packaging sector. Typically, these companies have an annual operating profit ranging between € 2 and 7 million. Of equal importance to us is that the management and NewPort teams click. This reflects our conviction that good business revolves on interpersonal relationships and mutual respect and trust.

Pharma Chemicals is a pharmaceutical laboratory dedicated to the field of chemicals for independent pharmacists.

We are an early-stage venture capital fund based in Amsterdam, Berlin, and Stockholm. We invest Europe-wide and have active investments in the Benelux, DACH, and Nordic regions. We are fully funded and ran by experienced entrepreneurs. We value eye-to-eye conversation, transparency, and complete teams. As investors, we specialize in models, rather than particular industries or verticals. We have more than a decade of experience in scaling marketplace, platform, and SaaS companies. Our sweet spot is pre Series-A We are proud of our colorful portfolio of over 40 investments (and awesome founders!) with strong exits including IENS (exit to Tripadvisor in 2015), Radionomy (exit to Vivendi in 2016), CheapCargo (exit to PostNL in 2017), United Wardrobe (Exit to Vinted in 2020), and Catawiki. If you are looking for an investor that is boots on the ground, please reach out to us via http://peak.capital/contact

Quadrum Capital is een ondernemende en onafhankelijke investeringsmaatschappij met een scherpe en eigenzinnige visie op zaken. Quadrum investeert middels fondsen en separate structuren in ondernemingen en beheert daarnaast een aantal directe strategische deelnemingen waarvan de kennis binnen haar netwerk gedeeld wordt.

Slingshot Ventures is a Dutch venture capital fund solely backed by successful entrepreneurs. We back ambitious, talented and charismatic entrepreneurs and actively help them accelerate their businesses with our knowledge, experience and international network of people and companies. By providing smart growth capital we help these start- and scale-ups catapult their business to the next level. This makes us the partner of choice for B2(B2)C focused fast growing ventures with international growth ambition and potential. We believe that proven entrepreneurs are the best inspiration for the next generation of entrepreneurs. That’s why both our team and our carefully selected group of investors consist of proven entrepreneurs and venture builders. This makes us truly hands-on in our investment approach. It’s what we call “inspirational growth capital”. We currently manage a portfolio of multiple investments, all with a base in the Netherlands and all with a cross-border ambition. Our portfolio includes companies such as Swishfund (online business lender), The Fabricant (digital fashion house)Temper (online marketplace for freelancers), Wasteless (dynamic pricing solution for supermarkets), Stox Energy Socks (innovative pressure socks), Fangage (all in one fan platform), Toothfairy (smart dental app), Check (shared e-moped platform) & Boldking (online male grooming).

Endeit Capital is a growth capital firm fueling internationalization and innovation. We have been boosting European tech scale-ups for almost two decades. Why do we do it? In Amsterdam, our journey as a European scale-up investor began in 2006. Now, with three offices across Europe and backed by 72 entrepreneurs, we are proud of our portfolio. Visionary entrepreneurs In the canvas of innovation, the belief in the power of technology drives us forward. Through the landscapes of AI, machine learning, deep learning, and algorithms, we embark on a mission of intelligent empowerment. It’s a commitment to visionary entrepreneurs who are the architects of the future. We’re proud to support entrepreneurs shaping the future. Our Buy&Build strategy effectiveness is underscored by 40 add-on acquisitions across 22 countries. European focus Rooted in Germany, the Netherlands, and Sweden, we catalyze change across Europe with our latest €300M+ fund. But it’s not all about the numbers. Together with a team of international colleagues, we celebrate personal connections. Entrepreneurs return for a second act; portfolio innovators join us as limited partners and former employees find their way back to contribute. Segments With AI as the overall denominator, we focus on Future of Work, SalesTech, Supply Chain & Procurement, FinTech and ClimateTech. Join us on a journey into the heart of innovation, where purposeful investment isn’t just a concept—it’s the force that shapes a brighter, more empowered future for all.

Ace Pharmaceuticals Belgium is the subsidiary of Ace Pharmaceuticals BV, established in the Netherlands. Ace is a pharmaceutical company with more than 120 employees. We develop, produce, register and sell medicines with a specific medical need. We do all this in-house. We are committed to making and keeping medicines with a specific medical need available. These are often medicines that are indispensable for a (small) specific group of patients or indication. Ace also takes care of the production and distribution of medicines for clinical research. In addition to registered medicines, we, as GMP manufacturer, also produce and supply pharmaceutical compounding on behalf of hospital pharmacies. In our state-of-the-art preparation facilities, we have all preparation facets in-house. We produce tablets and capsules, creams and ointments, but also aseptic and sterile preparations.